Diagnostic Value of Combined Detection of Serum TTR, PP13 and PLGF in Preeclampsia Patients

Background: To investigate the diagnostic value of serum transthyretin (TTR), placental protein 13 (PP13) and placental growth factor (PLGF) in preeclampsia patients. Methods: Sixty cases of pregnant women with preeclampsia who were examined in our hospital from January 2020 to February 2022 were re...

Full description

Bibliographic Details
Main Authors: Ying Jiang, Caifeng Deng, Xuehua Cheng, Xiaofeng Chen
Format: Article
Language:English
Published: IMR Press 2023-09-01
Series:Clinical and Experimental Obstetrics & Gynecology
Subjects:
Online Access:https://www.imrpress.com/journal/CEOG/50/9/10.31083/j.ceog5009195
_version_ 1827798108857171968
author Ying Jiang
Caifeng Deng
Xuehua Cheng
Xiaofeng Chen
author_facet Ying Jiang
Caifeng Deng
Xuehua Cheng
Xiaofeng Chen
author_sort Ying Jiang
collection DOAJ
description Background: To investigate the diagnostic value of serum transthyretin (TTR), placental protein 13 (PP13) and placental growth factor (PLGF) in preeclampsia patients. Methods: Sixty cases of pregnant women with preeclampsia who were examined in our hospital from January 2020 to February 2022 were retrospectively selected as the preeclampsia group, and 40 cases of healthy pregnant women who received regular physical examination in our hospital during the same period were selected as the control group. Based on the severity of the disease, the patients were allocated into two groups: mild preeclampsia group (n = 35) and severe preeclampsia group (n = 25). The levels of Serum TTR, PP13 and PLGF were compared between the groups. The correlation between serum TTR, PP13, PLGF and the patients was also analyzed by Spearman method, and receiver operating characteristic curve (ROC) and area under the curve (AUC) was adopted to analyze the clinical value of the separate and combined detection of serum TTR, PP13, PLGF in the diagnosis of preeclampsia. Results: The levels of serum TTR, PP13, PLGF in preeclampsia group were evidently lower versus the control group (p < 0.05), and those of patients in mild preeclampsia group were markedly lower versus the control group (p < 0.05), while those in severe preeclampsia group were markedly lower versus the mild preeclampsia group and control group (p < 0.05). Serum TTR, PP13, PLGF levels in preeclampsia patients were negatively correlated with the disease progression (r = –0.332, –0.315, –0.391, p < 0.05). The AUC values of TTR, PP13, PLGF in the single diagnosis of preeclampsia and their joint diagnosis were 0.812, 0.759, 0.867, and 0.887, respectively. The area under the ROC curve of TTR, PP13, and PLGF joint diagnosis of preeclampsia was higher than that of PP13 alone (p < 0.05). Conclusions: Serum TTR, PP13, and PLGF levels of preeclampsia patients were decreased compared with those of the control group, and the decrease was more significant with the aggravation of the disease, suggesting that TTR, PP13, and PLGF could be used as indicators to predict the onset and severity of preeclampsia. The combination of the three indicators could improve the diagnostic efficiency.
first_indexed 2024-03-11T19:31:16Z
format Article
id doaj.art-e2aa28ae2f3041c1a4a21ac485d92adf
institution Directory Open Access Journal
issn 0390-6663
language English
last_indexed 2024-03-11T19:31:16Z
publishDate 2023-09-01
publisher IMR Press
record_format Article
series Clinical and Experimental Obstetrics & Gynecology
spelling doaj.art-e2aa28ae2f3041c1a4a21ac485d92adf2023-10-06T13:17:09ZengIMR PressClinical and Experimental Obstetrics & Gynecology0390-66632023-09-0150919510.31083/j.ceog5009195S0390-6663(23)02039-0Diagnostic Value of Combined Detection of Serum TTR, PP13 and PLGF in Preeclampsia PatientsYing Jiang0Caifeng Deng1Xuehua Cheng2Xiaofeng Chen3Department of Obstetrics, The First Affiliated Hospital of Chengdu Medical College, 610500 Chengdu, Sichuan, ChinaDepartment of Obstetrics, The First Affiliated Hospital of Chengdu Medical College, 610500 Chengdu, Sichuan, ChinaDepartment of Obstetrics, The First Affiliated Hospital of Chengdu Medical College, 610500 Chengdu, Sichuan, ChinaDepartment of Obstetrics, The First Affiliated Hospital of Chengdu Medical College, 610500 Chengdu, Sichuan, ChinaBackground: To investigate the diagnostic value of serum transthyretin (TTR), placental protein 13 (PP13) and placental growth factor (PLGF) in preeclampsia patients. Methods: Sixty cases of pregnant women with preeclampsia who were examined in our hospital from January 2020 to February 2022 were retrospectively selected as the preeclampsia group, and 40 cases of healthy pregnant women who received regular physical examination in our hospital during the same period were selected as the control group. Based on the severity of the disease, the patients were allocated into two groups: mild preeclampsia group (n = 35) and severe preeclampsia group (n = 25). The levels of Serum TTR, PP13 and PLGF were compared between the groups. The correlation between serum TTR, PP13, PLGF and the patients was also analyzed by Spearman method, and receiver operating characteristic curve (ROC) and area under the curve (AUC) was adopted to analyze the clinical value of the separate and combined detection of serum TTR, PP13, PLGF in the diagnosis of preeclampsia. Results: The levels of serum TTR, PP13, PLGF in preeclampsia group were evidently lower versus the control group (p < 0.05), and those of patients in mild preeclampsia group were markedly lower versus the control group (p < 0.05), while those in severe preeclampsia group were markedly lower versus the mild preeclampsia group and control group (p < 0.05). Serum TTR, PP13, PLGF levels in preeclampsia patients were negatively correlated with the disease progression (r = –0.332, –0.315, –0.391, p < 0.05). The AUC values of TTR, PP13, PLGF in the single diagnosis of preeclampsia and their joint diagnosis were 0.812, 0.759, 0.867, and 0.887, respectively. The area under the ROC curve of TTR, PP13, and PLGF joint diagnosis of preeclampsia was higher than that of PP13 alone (p < 0.05). Conclusions: Serum TTR, PP13, and PLGF levels of preeclampsia patients were decreased compared with those of the control group, and the decrease was more significant with the aggravation of the disease, suggesting that TTR, PP13, and PLGF could be used as indicators to predict the onset and severity of preeclampsia. The combination of the three indicators could improve the diagnostic efficiency.https://www.imrpress.com/journal/CEOG/50/9/10.31083/j.ceog5009195transthyretinplacental protein 13placental growth factorpreeclampsiadiagnostic value
spellingShingle Ying Jiang
Caifeng Deng
Xuehua Cheng
Xiaofeng Chen
Diagnostic Value of Combined Detection of Serum TTR, PP13 and PLGF in Preeclampsia Patients
Clinical and Experimental Obstetrics & Gynecology
transthyretin
placental protein 13
placental growth factor
preeclampsia
diagnostic value
title Diagnostic Value of Combined Detection of Serum TTR, PP13 and PLGF in Preeclampsia Patients
title_full Diagnostic Value of Combined Detection of Serum TTR, PP13 and PLGF in Preeclampsia Patients
title_fullStr Diagnostic Value of Combined Detection of Serum TTR, PP13 and PLGF in Preeclampsia Patients
title_full_unstemmed Diagnostic Value of Combined Detection of Serum TTR, PP13 and PLGF in Preeclampsia Patients
title_short Diagnostic Value of Combined Detection of Serum TTR, PP13 and PLGF in Preeclampsia Patients
title_sort diagnostic value of combined detection of serum ttr pp13 and plgf in preeclampsia patients
topic transthyretin
placental protein 13
placental growth factor
preeclampsia
diagnostic value
url https://www.imrpress.com/journal/CEOG/50/9/10.31083/j.ceog5009195
work_keys_str_mv AT yingjiang diagnosticvalueofcombineddetectionofserumttrpp13andplgfinpreeclampsiapatients
AT caifengdeng diagnosticvalueofcombineddetectionofserumttrpp13andplgfinpreeclampsiapatients
AT xuehuacheng diagnosticvalueofcombineddetectionofserumttrpp13andplgfinpreeclampsiapatients
AT xiaofengchen diagnosticvalueofcombineddetectionofserumttrpp13andplgfinpreeclampsiapatients